bioMérieux Launches New Salmonella Testing Solution for Food Safety

bioMérieux Unveils GENE-UP® TYPER SLM

In a significant advancement for food safety, bioMérieux has introduced GENE-UP® TYPER SLM, a new real-time PCR solution designed specifically to aid in the rapid identification of Salmonella in food production environments. This product launch aims to enhance root cause analysis for food manufacturers globally.

Every year, Salmonella infections account for millions of cases worldwide, with a substantial number related to contaminated food. bioMérieux's timely introduction of this testing solution—launched on June 18, 2026—could substantially reduce foodborne illnesses and costly recalls for food producers. With a staggering 200 million to 1 billion infections reported annually and over 93 million cases of gastroenteritis resulting in approximately 155,000 fatalities, the implications of this product are vital for public health.

A Solution Tailored for the Industry

The GENE-UP® TYPER SLM focuses on Salmonella enterica subspecies enterica, the variant most commonly associated with human infection. This test is part of the GENE-UP® platform, which includes various assays aimed at streamlining the process of pathogen detection in food environments. By utilizing real-time PCR technology, this solution allows for quicker decision-making and rapid insights into contamination sources.

Food manufacturers often face challenges when contamination occurs, not only from a health perspective but also in terms of reputational damage and financial loss due to recalls. GENE-UP® TYPER SLM helps mitigate these risks by enabling manufacturers to conduct thorough root cause analyses and implement necessary corrections to their processes. Following pathogen detection, the DNA from samples is extracted and amplified with the relevant GENE-UP® TYPER assay. The resultant data is then uploaded to bioMérieux’s AUGMENTED-DX web portal, which uses machine learning to analyze the information.

Harnessing Advanced Technology for Food Safety

This innovative technology combines bioMérieux's extensive expertise with state-of-the-art algorithms to create a comprehensive genomic database. The system can assign unique identifiers for strains and group similar strains into clusters, building a historical analysis of contamination sources. Such detailed tracking allows manufacturers to improve their production controls significantly.

Yasha Mitrotti, Executive Vice President of Industrial Applications at bioMérieux, articulated the company’s commitment to innovation, emphasizing that this product launch marks a continuation of their efforts to provide cutting-edge solutions tailored to the ever-changing landscape of food safety. The success of the previously launched Listeria assay further solidifies the effectiveness of their approach in combating foodborne illnesses.

Collaborating for a Safer Future

To enhance the testing capabilities of the food and beverage sectors, bioMérieux has partnered with Mérieux NutriSciences—a global leader in food safety—to develop this solution. Mérieux NutriSciences will have co-exclusive rights for testing in several critical markets, ensuring that the GENE-UP® TYPER SLM is widely accessible to both large manufacturers and smaller processors.

In conclusion, the launch of GENE-UP® TYPER SLM represents a substantial advancement in the capability of food manufacturers to ensure consumer health and safety. As foodborne illness rates continue to be a pressing issue, innovative solutions such as this are essential for safeguarding public health and maintaining trust in food products worldwide. The GENE-UP® TYPER SLM test is now available worldwide, marking a new chapter in food safety efforts.